If you’re an investor in biotechnology and MedTech companies, two things should always be at the top of your mind: trends and team dynamics. According to Andrew Farquharson, companies must be hitting relevant trends that will drive innovation and return for investors. They also have to exhibit good team collaboration, chemistry, and commitment.
As the Managing Director at InCube Venture, Andrew spends most of his time investing in gene editing, cell therapy, biotech, and digital health. With decades of experience working in the life-science sector and an especially optimistic attitude, Andrew shares valuable insights on building a successful team in the startup world.
In this episode, we discuss the current trends and challenges in the life-science arena, the importance of impact-driven work, and the need to strike a perfect balance between innovation and practicality.
Do you have any thoughts? Please email us at hello@rosenmaninstitute.org.
Craig Mermel: Selling Science Fiction
Daniel Etra: Scaling the Right Level of Care
Peter Socarras: A Connection to Purpose
Joanna Drake: Investing in Care
Sandeep Akkaraju: Simplifying Care in the Modern World
Riddhiman Das: Delivering Breakthrough Innovations Using Secure Data
Yasi Baiani: Optimizing Healthcare Integration
Deborah Kilpatrick: Improving Everyday Health
Zack Gray: The Opioid Crises Treatment Gap
Patricia Bradley: The Full Continuum of Care
Alon Joffe: Bridging the Patient-Clinician Gap in Behavioral Health
A. J. Loiacono: The Tylenol Rule
Erin Harkless Moore: Underrepresented & Undercapitalized
David Hanson: The Future of AI
Richard Lungen: Looking Behind the Scenes
Ogi Kavazovic: A Broken System
Sean Saint: Standalone Success
David Mou: Telehealth Mental Revolution
Brad Hirsch: Revolutionizing Clinical Trials
Tamar Thompson: Coding Toward a Better Health-Policy Future
Create your
podcast in
minutes
It is Free
The emPOWERed Half Hour
NABOR® TALKS
U.S Property Podcast
Aligned Money Show
The Ramsey Show
Planet Money